Cargando…
Evidence to guide the optimal timing for pre‐chemotherapy blood tests for early breast, colorectal cancer and diffuse large B‐cell lymphoma
BACKGROUND: Re‐designing services and processes to meet growing demands in chemotherapy services is necessary with increasing treatments. There is little evidence guiding the timing and thresholds to be attained of pre‐chemotherapy blood assessments, namely neutrophils. METHODS: A survey was develop...
Autores principales: | Chambers, Pinkie, Wei, Li, Forster, Martin D., Kipps, Emma, Wong, Ian C. K., Jani, Yogini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607255/ https://www.ncbi.nlm.nih.gov/pubmed/34581509 http://dx.doi.org/10.1002/cam4.4316 |
Ejemplares similares
-
Patient factors and their impact on neutropenic events: a systematic review and meta-analysis
por: Chambers, Pinkie, et al.
Publicado: (2019) -
Capturing tumour heterogeneity in pre- and post-chemotherapy colorectal cancer ascites-derived cells using single-cell RNA-sequencing
por: Poonpanichakul, Tiraput, et al.
Publicado: (2021) -
Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients
por: Hu, Maogui, et al.
Publicado: (2021) -
Development and validation of a risk score (Delay-7) to predict the occurrence of a treatment delay following cycle 1 chemotherapy
por: Chambers, P., et al.
Publicado: (2022) -
β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway
por: Hu, Tonglin, et al.
Publicado: (2020)